Exact Mass: 568.155
Exact Mass Matches: 568.155
Found 22 metabolites which its exact mass value is equals to given mass value 568.155,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Azilsartan medoxomil
(5-methyl-2-oxo-2H-1,3-dioxol-4-yl)methyl 2-ethoxy-1-({4-[2-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)phenyl]phenyl}methyl)-1H-1,3-benzodiazole-7-carboxylate
6,8-Dimethoxy-2,3-trans-2-(4-hydroxy-2,3-dimethoxyphenyl)-9-(5-hydroxy-2-methoxyphenyl)-3-hydroxymethyl-2,3-dihydro-7H-1,4-dioxono[2,3-h]chromene-7-one
6,8-Dimethoxy-2,3-trans-2- (4-hydroxy-2,3-dimethoxyphenyl) -9- (5-hydroxy-2-methoxyphenyl) -3-hydroxymethyl-2,3-dihydro-7H-1,4-dioxono [ 2,3-h ] chromene-7-one
4-O-acetyl-7-O-beta-L-fucopyranosyldiphyllin|4-O-acetylpatentiflorin B
4-O-acetyl-7-O-beta-L-fucopyranosyldiphyllin|4-O-acetylpatentiflorin B
2,3-trans-2-(4-hydroxy-2,3-dimethoxyphenyl)-9-(5-hydroxy-2-methoxyphenyl)-2-hydroxymethyl-2,3-dihydro-7H-1,4-dioxino<2,3-h>chromen-7-one
2,3-trans-2-(4-hydroxy-2,3-dimethoxyphenyl)-9-(5-hydroxy-2-methoxyphenyl)-2-hydroxymethyl-2,3-dihydro-7H-1,4-dioxino<2,3-h>chromen-7-one
Azilsartan medoxomil
Azilsartan medoxomil
C - Cardiovascular system > C09 - Agents acting on the renin-angiotensin system > C09C - Angiotensin ii receptor blockers (arbs), plain > C09CA - Angiotensin ii receptor blockers (arbs), plain C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C66930 - Angiotensin II Receptor Antagonist D057911 - Angiotensin Receptor Antagonists > D047228 - Angiotensin II Type 1 Receptor Blockers Azilsartan medoxomil (TAK 491) is an orally administered angiotensin II receptor type 1 antagonist with IC50 of 0.62 nM, which used in the treatment of adults with essential hypertension[1][2][3][4].
1-(2-methoxy-2-methylpropanoyl)oxyethyl (6R,7R)-3-(carbamoyloxymethyl)-7-[[(2Z)-2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1-(2-methoxy-2-methylpropanoyl)oxyethyl (6R,7R)-3-(carbamoyloxymethyl)-7-[[(2Z)-2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
6-{[9-(2h-1,3-benzodioxol-5-yl)-6,7-dimethoxy-1-oxo-3h-naphtho[2,3-c]furan-4-yl]oxy}-4,5-dihydroxy-2-methyloxan-3-yl acetate
6-{[9-(2h-1,3-benzodioxol-5-yl)-6,7-dimethoxy-1-oxo-3h-naphtho[2,3-c]furan-4-yl]oxy}-4,5-dihydroxy-2-methyloxan-3-yl acetate
{3,4,5-trihydroxy-6-[1,4,5-trihydroxy-7-(hydroxymethyl)-9h-xanthen-9-yl]oxan-2-yl}methyl 3-(4-hydroxyphenyl)prop-2-enoate
{3,4,5-trihydroxy-6-[1,4,5-trihydroxy-7-(hydroxymethyl)-9h-xanthen-9-yl]oxan-2-yl}methyl 3-(4-hydroxyphenyl)prop-2-enoate
(2s,3s,4s,5s,6r)-6-{[9-(2h-1,3-benzodioxol-5-yl)-6,7-dimethoxy-1-oxo-3h-naphtho[2,3-c]furan-4-yl]oxy}-4,5-dihydroxy-2-methyloxan-3-yl acetate
(2s,3s,4s,5s,6r)-6-{[9-(2h-1,3-benzodioxol-5-yl)-6,7-dimethoxy-1-oxo-3h-naphtho[2,3-c]furan-4-yl]oxy}-4,5-dihydroxy-2-methyloxan-3-yl acetate
2-(4-hydroxy-2,3-dimethoxyphenyl)-9-(5-hydroxy-2-methoxyphenyl)-3-(hydroxymethyl)-6,8-dimethoxy-2h,3h-[1,4]dioxino[2,3-h]chromen-7-one
2-(4-hydroxy-2,3-dimethoxyphenyl)-9-(5-hydroxy-2-methoxyphenyl)-3-(hydroxymethyl)-6,8-dimethoxy-2h,3h-[1,4]dioxino[2,3-h]chromen-7-one
[(2r,3s,4r,5r,6r)-3,4,5-trihydroxy-6-[(9s)-1,4,5-trihydroxy-7-(hydroxymethyl)-9h-xanthen-9-yl]oxan-2-yl]methyl (2e)-3-(4-hydroxyphenyl)prop-2-enoate
[(2r,3s,4r,5r,6r)-3,4,5-trihydroxy-6-[(9s)-1,4,5-trihydroxy-7-(hydroxymethyl)-9h-xanthen-9-yl]oxan-2-yl]methyl (2e)-3-(4-hydroxyphenyl)prop-2-enoate
methyl 3-(3,4-dihydroxyphenyl)-6-(3-{[3-(3,4-dihydroxyphenyl)-1-methoxy-1-oxopropan-2-yl]oxy}-3-oxoprop-1-en-1-yl)-7-hydroxy-8-oxobicyclo[2.2.2]oct-5-ene-2-carboxylate
methyl 3-(3,4-dihydroxyphenyl)-6-(3-{[3-(3,4-dihydroxyphenyl)-1-methoxy-1-oxopropan-2-yl]oxy}-3-oxoprop-1-en-1-yl)-7-hydroxy-8-oxobicyclo[2.2.2]oct-5-ene-2-carboxylate
2-[2-(3,4-dihydroxyphenyl)-5-[(3,4-dihydroxyphenyl)methyl]-6-oxooxan-2-yl]-4-hydroxyoxolan-3-yl 3,5-dihydroxybenzoate
2-[2-(3,4-dihydroxyphenyl)-5-[(3,4-dihydroxyphenyl)methyl]-6-oxooxan-2-yl]-4-hydroxyoxolan-3-yl 3,5-dihydroxybenzoate
methyl (1s,2r,3s,4s,7s)-3-(3,4-dihydroxyphenyl)-6-[(1e)-3-{[(2s)-3-(3,4-dihydroxyphenyl)-1-methoxy-1-oxopropan-2-yl]oxy}-3-oxoprop-1-en-1-yl]-7-hydroxy-8-oxobicyclo[2.2.2]oct-5-ene-2-carboxylate
methyl (1s,2r,3s,4s,7s)-3-(3,4-dihydroxyphenyl)-6-[(1e)-3-{[(2s)-3-(3,4-dihydroxyphenyl)-1-methoxy-1-oxopropan-2-yl]oxy}-3-oxoprop-1-en-1-yl]-7-hydroxy-8-oxobicyclo[2.2.2]oct-5-ene-2-carboxylate
(2r,3r)-2-(4-hydroxy-2,3-dimethoxyphenyl)-9-(5-hydroxy-2-methoxyphenyl)-3-(hydroxymethyl)-6,8-dimethoxy-2h,3h-[1,4]dioxino[2,3-h]chromen-7-one
(2r,3r)-2-(4-hydroxy-2,3-dimethoxyphenyl)-9-(5-hydroxy-2-methoxyphenyl)-3-(hydroxymethyl)-6,8-dimethoxy-2h,3h-[1,4]dioxino[2,3-h]chromen-7-one
